Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrate esters or chalcogen analogues thereof
Reexamination Certificate
2007-11-20
2007-11-20
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrate esters or chalcogen analogues thereof
C514S509000, C568S941000
Reexamination Certificate
active
11590770
ABSTRACT:
Statin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for treating and/or preventing several diseases, in particular coronary syndromes, neurodegenerative disorders as well as for reducing cholesterol levels.
REFERENCES:
patent: 6476235 (2002-11-01), Butler et al.
patent: 6573385 (2003-06-01), Sambasivam et al.
patent: 97/16405 (1997-05-01), None
patent: 98/21193 (1998-05-01), None
patent: 00/61537 (2000-10-01), None
patent: 00/61541 (2000-10-01), None
patent: 01/12584 (2001-02-01), None
patent: 03/007846 (2003-01-01), None
Semeraro et al., “Direct Induction of Tissue Factor Synthesis by Endotoxin In Human Macrophages From Diverse Anatomical Sites”, Immunology 50 529-535, 1983.
Vezza et al., “Prostaglandin E2Potentiates Platelet Aggregation by Priming Protein Kinase C”, Blood 82 2704-2713, 1993.
Rossiello et al., “Fibrin Down-regulates LPS-and PMA-induced Tissue Factor Expression by Blood Momonuclear Cells”, Thromb Haemost 84 453-459, 2000.
Momi et al., “Prevention of Pulmonary Thromboembolism by NCX 4016, a Nitric Oxide-Releasing Asprin”, European Journal of Pharmacology 397 177-185, 2000.
Emanueli et al., “Local Delivery of Human Tissue Kallikrein Gene Accelerates Spontaneous Angiogenesis in Mouse Model of Hindlimb Ischemia”, Circulation 2/9 125-132, 2001.
Wanstall et al., “Vascular Smooth Muscle Relaxation Mediated by Nitric Oxide Donors: A Comparison with Acetylcholine, Nitric Oxide and Nitroxyl Ion”, Brittish Journal of Pharmacology 134 463-472, 2001.
Bonetti et al., “Statin Effects Beyond Lipid Lowering—Are They Clinically Relevant?”, European Heart Journal 24 225-248, 2003.
Ongini et al., “Nitric Oxide(NO)-Releasing Statin Derivaties, A Class of Drugs Showing Enhanced Antoproliferative And Antiinflammatory Properties”, PNAS 101 8497-8502, 2004.
Bonazzi et al., “New Nitric Oxide(NO)-realsing Statin Dervatives With Enhanced Anti-Inflammatory Properties”, AHA Scientific Sessions 9-12, 2003.
Dever et al., “Effects of No-Pravastain on Leukocyte Adhesion and Reactive Oxygen Speices Generation in Control and Apoe Knockout Mice”, AHA Scientific Sessions 9-12, 2003.
Carini et al., “In Vitro Metabolism of a nitroderivative of acetylsalicylic acid(NCX4016)by rat liver: LC and LC-MS studies”, J. Pharm. Biomed. Anal. 29, 2002, pp. 1061-1071.
Chiroli et al., “Nitric Oxide-Donating Non-Sterodial Anti-Inflammatory Drugs: The Case of Nitroderivatives of Asprin”, European J. Med. Chem. 38, 2003, pp. 441-446.
Roseiello et al., “Nitropravastatin(NCX6550)Exerts an Antiplatelet/ Antithrombotic Activity and Inhabits Tissue Factor Expression”, AHA Scientific Sessions 9-12, 2003.
Emanueli et al., “The Nitric Oxide(NO)-Releasing Pravastain Derivative, NCX 6550, Potentiates Reparative Angiogenesis In A Mouse Model Of Peripheral Ischemia”, BPS, 2003.
Guzzetta et al., “Nitric Oxide(NO)-Releasing Statins: A New Class of Drugs Combining NO and Statin Properties”, BPS, 2003.
Momi et al., “Antiplatelet and Antithrombotic Activity of NCX 6550, A Nitrick Oxide(NO)-Releasing Derivative of Pravastain”, BPS, 2003.
Guzzetta et al., “Novel Nitric Ozide(NO)-Releasing Derivatives of Statins Modulate Cellular NO Homeostasis Acting on eNOS and iNOS Expressions”, 9thInternational Conference on Alzheimer's Disease and Related Disorders, 2004.
Baraldi et al., “Synthesis of Nitro Esters of PRedisolone, New Compounds Combining Pharmacology Properties of Both Glucocorticoids and Niitric Oxide”, J. Med. Chem. 2004, vol. 47,711-719.
Burgaud et al., “Nitric Oxide-Releasing Drugs A Novel Class of Effective and Safe Therapeutic Agents”, Ann. N.Y. Acad. Sci. 962: 360-371, 2002.
Hobbs et al., “Achievement of English National Service Framework Lipid-lowering Goals: Pooled Data from Recent Comperative Treatment Trials of Statins at Starting Doses”, J. Clin. Pract., vol. 59, 10 1171-1177, 2005.
Omori et al., “Direct in Vivo Evidence of Vascular Statin: A Single Dose of Cerivastatin Rapidly Increases Vascular Endothelial Responsiveness in Healthy Normocholesterolaemic Subjects”, British J. Clin. Pharmacol., vol. 54, 395-396, 2002.
Shishehbor et al., “Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways”, Circulation 2003; 108: 426-431.
Laufs et al., “Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activiation, and Protects From Cerebral Ischemia in Normocholesterolermic Mice Editorial Comment”, Stroke, 2000: 32: 2442-2449.
Benedini Francesca
Del Soldato Piero
Ongini Ennio
Arent & Fox LLP
Cho Jennifer Y
Eyler Yvonne
Nicox S.A.
LandOfFree
Statin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Statin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Statin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3809521